cp wire

CP Wire Articles

Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer

Seres Therapeutics, Inc. (Nasdaq:MCRB) announced on 10/22/18 the appointment of Kevin Horgan, M.D., as Executive Vice President and Chief Medical Officer. Dr. Horgan will lead Seres’ clinical... read more

Mon, 10/22/18 - 05:29 pm
BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
  • Pamiparib is currently in Phase 3 trials globally and in China as a monotherapy
  • Of 23 patients with solid tumors, Ten had a best response of stable disease; four patients had a best... read more
Mon, 10/22/18 - 10:01 am
New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer
  • In the Tumor Treating Fields plus gemcitabine cohort, progression free survival and overall survival were each more than double those of the gemcitabine-treated historical control
  • ... read more
Mon, 10/22/18 - 09:47 am
Rebiotix to Report on Development of its Microbiome Health Index
  • The Index is a measurement meant to assess the extent of microbiome restoration following microbiota based therapy
  • Rebiotix is developing two microbiota based formulations to treat... read more
Mon, 10/22/18 - 09:31 am
TP Therapeutics Secures $80 Million Mezzanine Financing


TP Therapeutics announced on 10/19/18 its completion of an $80 million round of mezzanine financing. Foresite Capital and venBio Partners led the investment syndicate, with participation from... read more

Fri, 10/19/18 - 09:29 am

Pages